再感染

细菌DNA图谱分析幽门螺杆菌阳性病人治疗后的复发和再感染

Analyses of recrudescence and reinfection of Helicobacter pylori infection after antimicrobial treatment by DNA fingerprinting

人群化疗后血吸虫再感染影响因素的非条件Logistic回归分析

Unconditional logistic regression analysis on factors related with Schistosoma japonicum reinfection after chemotherapy

一种叫作吡啶酮的新型抗艾滋病药物能促使艾滋病毒变异，使其不能繁殖，也不会再感染新的细胞。

A newer anti-HIV drug called pyridinone caused HIV to mutate into a form which could not reproduce or infect new cells

同种异体原位肝移植术后预防HBV再感染的临床研究

A Clinical Study about the Prophylaxis of HBV Reinfection after Orthotopic Liver Transplantation

用日本血吸虫病化疗后再感染人血清对成虫cDNA文库的初步筛选

Immunoscreening of cDNA clones expressing Schistosoma japonicum antigens by serum from reinfected people

糖皮质激素被证实与HBV再感染有关。

Corticosteroids is related with HBV reinfection .

结论拉米夫定联合肌肉注射剂型的人乙型肝炎免疫球蛋白可有效预防肝移植术后HBV再感染；

Conclusions Combination of intramuscular HBIg and Lamivudine as prophylaxis of HBV reinfection is effective .

组胺H2受体抑制剂西米替丁对大白鼠抵抗华支睾吸虫再感染拮抗作用的实验研究

Study on the effect of histamine H_2 receptor inhibitor cimetidine on the resistance to reinfection with Clonorchis sinensis in rats

特异性IgG抗体在同源与异种疟原虫再感染中的作用研究

The effect of specific IgG antibody in re-infected with homologous or heterogenic Plasmodium

原发性感染、再感染根管中古细菌的RT-PCR分析

Detection of archaea in root canal of primary and secondary endodontic infections by RT-PCR

拉米夫定耐药的HBV再感染者阿德福韦酯治疗前后HBV多聚酶基因区序列演变的研究

Evolution of HBV polymerase gene as a result of adefovir dipivoxil treatment in liver transplant patients with lamivudine resistance

结论拉米夫定+HBIg或拉米夫定+阿德夫韦+HBIg联合应用，可以有效预防HBV相关性肝病肝移植后HBV的再感染。

Conclusions Lamivudine / HBIg or Lamivudine / Adefovir / HBIg combination therapy can effectively prevent HBV reinfection following liver transplantation .

观察术后开始负重时间，每月拍X射线片观察骨缺损修复及再感染发生情况。

The time of weight loading after operation was observed , and X-ray examination was monthly conducted to observe the repair of bone defect and re-infection .

结果CMV再感染率为14.5%（9/62）。

Results The overall incidence of CMV reinfection was 14.5 % ( 9 / 62 ) .

结论肌注型HBIg联合核苷类抗病毒药物能有效预防肝移植术后HBV再感染。

Conclusion Combination of intramuscular HBIg and nucleoside analogs as prophylaxis of HBV reinfection is effective .

目的：获取编码可能指示再感染倾向的日本血吸虫特异免疫分子的cDNA克隆。

AIM : To obtain cDNA clones coding for S. japonicum ( Sj ) reinfection related specific immunologic molecules for vaccination or diagnosis .

对无临床症状的CMV再感染者进行及时、规范的治疗是防止CMV病发生的关键。

Preemptive strategy for asymptomatic CMV reinfection is the key to prevent it from developing CMV disease .

结论尿素变性ELISA实验是鉴别初次HCMV感染和再感染或体内病毒活化的有效方法；

Conclusions The urea denaturation ELISA test can be applied to HCMV to determine primary infection and reinfection or reactivation .

目的评价小剂量肌肉注射剂型乙肝免疫球蛋白（HBIg）联合核苷类抗病毒药物预防肝移植术后乙肝病毒（HBV）再感染的疗效。

Objective To evaluate the efficacy of combination of intramuscular HBIg and nucleoside analogs of HBV reinfection .

目的分析乙型肝炎病毒（HBV）相关性肝病肝移植术后HBV再感染的原因及防治经验。

Objective To analyse the reasons for hepatitis B virus ( HBV ) reinfection following orthotopic liver transplantation and the experience of preventing HBV reinfection .

HBVdna定量检测有较高的灵敏度，能早期诊断HBV的再感染，有利于临床治疗；

The quantitative polymerase chain reaction assay of HBV DNA was sensitive for the earlier diagnosis of HBV reinfection after liver transplantation and beneficial to the clinical treatment .

观察1周、8周、6个月后的幽门螺杆菌的Hp根除率，消化性溃疡愈合情况、幽门螺杆菌的再感染率及消化性溃疡复发率。

The remove rate of Hp , ulcer healing , reinfection of Hp and relapse of ulcer after week , 8 weeks and 6 months were observed .

肌注型HBIg预防肝移植术后乙肝病毒再感染的疗效分析

Efficacy of intramuscular HBIg in preventing hepatitis B virus reinfection after liver transplantation

抗-HBs抗体可用来预防肝移植后HBV的再感染和母婴垂直感染，但这有赖于HBsAg与抗-HBs抗体之间的相互作用。

Hepatitis B immunoglobulin could be used to protect the patient from reinfection after liver transplantation , but this effect rely on the interaction of HBsAg and anti-HBs .

在未采取预防HBV再感染措施的患者中，OLT术后HBV再感染率高达85%。

Without prophylactic regimens , patients develop recurrent infection and severe hepatitis leading to accelerated graft failure . The reinfection rate as was high as 85 % .

结果：临床实验组在平均随访15.3个月后，27例患者中无一例术后HBV再感染，再感染率为0%。

Results : After a median follow-up of 15.3 months , none of 27 patients in the clinical experiment group is reinfected with HBV and the rate of HBV reinfection post-LT is 0 % .

目的：探讨病毒学因素对原位肝移植（OLT）后乙肝病毒再感染的影响（包括术前病毒含量、HBVs基因变异）。

Objective : To make an inquiry into the relationship between virological factors ( HBV DNA quantity pre-OLT and HBV S gene mutation ) and HBV reinfection after OLT .

能在根管内维持一定时间的有效药物浓度达10d以上，防止根管再感染。

It could maintain the effective drug concentration for a long time ( 10 days ) in root canal .

通过黄连气雾剂局部作用于口腔，清除口腔内的Hp，阻断幽门螺杆菌的体内再感染途径，以达到根治Hp的目的。

Through clear away Hp in the oral cavity with Rhizoma Coptidis aerosol to chop broken the reinfection channel of Helicobacter Pylori in the body , in order to eradicating Hp in the body .

术后第一天HBsAg阳性者再感染率为21·1%，阴性者3·7%，两组间差异有统计学意义（P<0·05）。

Among patients with serum HBsAg positive and negative at the first day after liver transplantation , the reinfection risks were 21.1 % and 3.7 % respectively ( P < 0.05 ) .